GBA1 and drug-induced dyskinesia: Carriers of the GBA mutation may present with a spectrum of clinical phenotypes, from akinetic-rigid Parkinson disease to dementia with Lewy bodies, with variable motor complications in the form of dyskinesia and wearing-off.